Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease

被引:252
|
作者
Merriman, Raphael B.
Ferrell, Linda D.
Patti, Marco G.
Weston, Shiobhan R.
Pabst, Mark S.
Aouizerat, Bradley E.
Bass, Nathan M.
机构
[1] Univ Calif San Francisco, Dept Med, Div Gastroenterol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Physiol Nursing, San Francisco, CA 94143 USA
关键词
D O I
10.1002/hep.21346
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In the absence of surrogate markers, the evaluation of suspected nonalcoholic fatty liver disease (NAFLD) is highly dependent on histological examination. The extent of sampling variability affecting the reliability of a single liver biopsy in patients with suspected NAFLD is poorly characterized. This prospective study aimed to correlate precise histological findings in paired biopsies-right and left lobe-in the diagnosis of NAFLD in morbidly obese subjects undergoing bariatric surgery employing both Brunt and Matteoni classifications and the NAFLD Activity Score (NAS). We also aimed to determine whether the composite histopathological findings of the two biopsies would improve diagnostic accuracy. Consecutive subjects had an intraoperative biopsy from both right and left lobes, evaluated and scored in a blinded manner. Intraobserver agreement was also assessed. Kappa coefficients of agreement were calculated. Forty-one subjects had acceptable biopsies. Agreement for steatosis was excellent and moderate for fibrosis. Concordance was only fair for most features of necroinflammation. Intraobserver agreement was only moderate for lobular inflammation. Excellent agreement was seen for the diagnosis of NASH using Brunt criteria and good agreement when using Matteoni and NAS scoring systems. Composite biopsy data particularly improved identification of hepatocyte ballooning. The diagnostic accuracy also improved substantially when composite features were compared with single-sided biopsy features, especially for the Matteoni and NAS scoring systems. In conclusion, significant sampling variability occurs in NAFLD, particularly for features of necroinflammation. This should be factored into the design of clinical trials and studies of the natural history of the disease.
引用
收藏
页码:874 / 880
页数:7
相关论文
共 50 条
  • [1] Comparison of paired liver biopsies in morbidly obese subjects with nonalcoholic fatty liver disease
    Abrams, GA
    Jhala, N
    Lazenby, A
    Kunde, S
    Leath, T
    Ragland, B
    Clements, R
    GASTROENTEROLOGY, 2004, 126 (04) : A755 - A755
  • [2] Correlation of Paired Liver Biopsies for Nonalcoholic Fatty Liver Disease (NAFLD) in Morbidly Obese Patients Undergoing Roux-en-Y Gastric Bypass
    El Younis, Cherif M.
    Patel, Prem
    Petrova, Ana
    Rajpal, Sanjeev
    Kim, Dong-Sung
    GASTROENTEROLOGY, 2011, 140 (05) : S700 - S701
  • [3] Histologic correlation of paired right lobe and left lobe liver biopsies in morbidly obese individuals with suspected non alcoholic fatty liver disease.
    Merriman, RB
    Ferrell, LD
    Patti, MG
    Ostroff, JW
    Bagetelos, K
    Aouizerat, BE
    Bass, NM
    HEPATOLOGY, 2003, 38 (04) : 232A - 232A
  • [4] Agreement of Paired Liver Biopsies for Nonalcoholic Fatty Liver Disease (NAFLD) in Morbidly Obese Patients Undergoing Roux-en-Y Gastric Bypass
    El Younis, Cherif
    Patel, Prem
    Zhang, Yatian
    Petrova, Ana
    Rajpal, Sanjeev
    Kim, Dong-Sung
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S126 - S127
  • [5] Performance of Noninvasive Liver Fibrosis Tests in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease
    Saleh A. Alqahtani
    Pegah Golabi
    James M. Paik
    Brian Lam
    Amir H. Moazez
    Hazem A. Elariny
    Zachary Goodman
    Zobair M. Younossi
    Obesity Surgery, 2021, 31 : 2002 - 2010
  • [6] Performance of Noninvasive Liver Fibrosis Tests in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease
    Alqahtani, Saleh A.
    Golabi, Pegah
    Paik, James M.
    Lam, Brian
    Moazez, Amir H.
    Elariny, Hazem A.
    Goodman, Zachary
    Younossi, Zobair M.
    OBESITY SURGERY, 2021, 31 (05) : 2002 - 2010
  • [7] Hepcidin in morbidly obese women with nonalcoholic fatty liver disease
    Auguet, Teresa
    Aragones, Gemma
    Berlanga, Alba
    Martinez, Salome
    Sabench, Fatima
    Binetti, Jessica
    Aguilar, Carmen
    Porras, Jose Antonio
    Molina, Alicia
    Del Castillo, Daniel
    Richart, Cristobal
    PLOS ONE, 2017, 12 (10):
  • [8] Hepatic Gene Networks in Morbidly Obese Patients With Nonalcoholic Fatty Liver Disease
    Samer Gawrieh
    Tesfaye M. Baye
    Melanie Carless
    James Wallace
    Richard Komorowski
    David E. Kleiner
    Deborah Andris
    Bassem Makladi
    Regina Cole
    Michael Charlton
    Joanne Curran
    Thomas D. Dyer
    Jac Charlesworth
    Russell Wilke
    John Blangero
    Ahmed H. Kissebah
    Michael Olivier
    Obesity Surgery, 2010, 20 : 1698 - 1709
  • [9] THE APPLICATION OF LIPIDOMIC ANALYSIS ON NONALCOHOLIC FATTY LIVER DISEASE IN MORBIDLY OBESE PATIENTS
    Hsieh, Yin-Ru
    Wu, Hua-Chien
    Wang, Weu
    Chang, Ching-Wen
    Chang, I-Wei
    Chen, Chi-Long
    Chang, Chun-Chao
    Kao, Wei-Yu
    Huang, Shih-Yi
    HEPATOLOGY, 2023, 78 : S885 - S885
  • [10] Prediction of advanced fibrosis in morbidly obese patients with nonalcoholic fatty liver disease
    Singh, Tavankit
    Rocio, Lopez
    Dasarathy, Srinivasan
    McCullough, Arthur J.
    HEPATOLOGY, 2017, 66 : 1123A - 1124A